News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Camtronics Medical Systems (ALOG) Introduces Cardiovascular Screening Software For VERICIS Cardiovascular Information System



10/19/2005 5:10:28 PM

HARTLAND, Wis., Nov. 10 /PRNewswire-FirstCall/ -- Camtronics Medical Systems, Ltd., a subsidiary of Analogic Corporation , announced the introduction of CIMT Screen(TM), a sophisticated measurement, analysis, and reporting software package that can help identify patients with pre-clinical atherosclerosis and clarify cardiovascular risk. CIMT Screen is part of VERICIS(R) for Vascular Ultrasound, a new application from Camtronics that is tailored to the image management and reporting requirements of non-invasive vascular procedures.

Camtronics' CIMT Screen software enables the measurement and analysis of carotid intima-media thickness (CIMT), a non-invasive test that quantifies an individual's current atherosclerotic burden. Using these measurements and other risk factors, the software derives a mathematical estimate of an individual's "vascular age" (pending FDA review). In clinical practice at the University of Wisconsin Hospital and Clinics (UWHC), substituting vascular age for chronological age has been shown to improve the applicability of population-based CHD risk estimates.

"Measuring CIMT is a promising new method for individualizing cardiac risk assessment," says James H. Stein, MD, FACC, FAHA, lead clinical developer of CIMT Screen and Associate Director of Preventive Cardiology, University of Wisconsin Medical School and UW Health Heart and Vascular Care. "We have successfully integrated CIMT analysis as a component of our preventive cardiology program at UWHC. In fact, more than 70 percent of patients who've come through our program have been found to be at greater risk of a future cardiovascular event than what would have been suggested by standard risk factors."

Dr. Stein noted that acceptance of CIMT analysis as a valuable adjunct to standard CHD risk assessment is growing. Three years ago the American Heart Association Prevention Conference V concluded that CIMT "can now be considered for further clarification of CHD risk assessment." (Circulation 2000;101:E16- E22)

Dr. Stein will be presenting an abstract regarding CIMT measurements and Metabolic Syndrome at the American Heart Association Scientific Sessions, in Orlando, Florida. Data in this manuscript was used in the development of the CIMT Screen software. He will also be on hand to answer questions in Camtronics booth (#821) at the technical exhibits from 10 am to 12 pm on Tuesday, November 11th.

CIMT Screen is available as a component of VERICIS for Vascular Ultrasound, a complete image and information management solution for non-invasive vascular procedures. Key features include: flexible DICOM study acquisition with Doppler audio, including voice annotation, immediate network access to present and prior studies, powerful image review and analysis capabilities, and integrated, domain-specific clinical reporting including knowledge bases for peripheral vascular, neuro-vascular and CIMT.

"More and more, we are seeing our customers performing non-invasive vascular exams in the cardiology department," says David Tolan, VERICIS Business Manager. "They have found our image acquisition technology, which is unique in its ability to capture dynamic images, Doppler audio and voice annotation simultaneously, to be ideal for the exam protocols of vascular ultrasound. And now with specialized measurement and reporting tools such as CIMT Screen, we have expanded the reach of the VERICIS platform to support preventive cardiology."

VERICIS for Vascular Ultrasound is part of the comprehensive VERICIS Cardiovascular Information System -- the first information management system that captures patient data across the continuum of cardiovascular care. Built on a single information technology platform, VERICIS integrates data from different sites (office, clinic, hospital) and different sources (interventional and diagnostic x-ray angiography, echo, nuclear, MR, hemodynamics, reports, HIS) to create a comprehensive digital record on the cardiac patient.

About Camtronics Medical Systems

Camtronics Medical Systems, Ltd., a subsidiary of Analogic Corporation, was founded in 1986 and is a market leader in cardiovascular information management and hemodynamic monitoring technology. Its industry-leading VERICIS(TM) Cardiovascular Information System provides single point access to the complete cardiovascular patient record, including both inpatient and outpatient data. Camtronics operates engineering, manufacturing, sales and marketing, and customer support activities from its headquarters near Milwaukee, Wisconsin as well as technology development centers in Winter Park, FL and Ottawa, Ontario, Canada. For more information call 1-800-634-5151 or visit http://www.camtronics.com/ .

Camtronics Medical Systems, Ltd.

CONTACT: Therese Weiter, Marketing Director of Camtronics MedicalSystems, +1-262-367-0700


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES